Abstract:Ubiquitin ligases are proteins with the ability to trigger non-degradative signaling or proteasomal destruction by attracting substrates and facilitating ubiquitin transfer onto target proteins. Over the years, there has been a continuous discovery of new ubiquitin ligases, and Kelch-like protein 20 (KLHL20) is one of the most recent discoveries that have several biological roles which include its role in ubiquitin ligase activities. KLHL20 binds as a substrate component of ubiquitin ligase Cullin3 (Cul3). Several substrates for ubiquitin ligases (KLHL20 based) have been reported, these include Unc-51 Like Autophagy Activating Kinase 1 (ULK1), promyelocytic leukemia (PML), and Death Associated Protein Kinase 1 (DAPK1). KLHL20 shows multiple cell functions linked to several human diseases through ubiquitination of these substrates. Current literature shows that KLHL20 ubiquitin ligase regulates malignancies in humans and also suggests how important it is to develop regulating agents for tumour-suppressive KLHL20 to prevent tumourigenesis, Recent research has highlighted its potential therapeutic implications in several areas. In oncology, KLHL20's regulatory role in protein degradation pathways suggests that its targeting could offer novel strategies for cancer treatment by modulating the stability of proteins involved in tumour growth and survival. In neurodegenerative diseases, KLHL20's function in maintaining protein homeostasis positions it as a potential target for therapies aimed at managing protein aggregation and cellular stress. Here, we review the functions of KLHL20 during the carcinogenesis process, looking at its role in cancer progression, and regulation of ubiquitination events mediated by KLHL20 in human cancers, as well as its potential therapeutic interventions.

The role of the ubiquitin-editing enzyme A20 in diseases of the central nervous system and other pathological processes

Advances in the Study of the Ubiquitin-Editing Enzyme A20

Neuroprotective Effect of A20 on TNF-Induced Postischemic Apoptosis

The Complexity of Being A20: From Biological Functions to Genetic Associations

Antiapoptotic Effect Both in Vivo and in Vitro of A20 Gene when Transfected into Rat Hippocampal Neurons

Roles of A20 in autoimmune diseases

A20 in Kidney Transplantation and Autoimmunity

A20 intrinsically influences human effector T‐cell survival and function by regulating both NF‐κB and JNK signaling

A20 functions as a negative regulator in macrophage for DSS-induced colitis

Current research into A20 mediation of allergic respiratory diseases and its potential usefulness as a therapeutic target

The role of zinc ifnger protein A20 in immune regulation of dendritic cells and in the pathogenesis of inlfammatory bowel disease

Degradation of Ubiquitin-Editing Enzyme A20 following Autophagy Activation Promotes RNF168 Nuclear Translocation and NF-κB Activation in Lupus Nephritis

A20 Protects Against Arthritis by Regulation of the NLRP3 Inflammasome

A20 controls expression of beta-cell regulatory genes and transcription factors

A20 Inhibits Intraocular Inflammation in Mice by Regulating the Function of CD4+T Cells and RPE Cells

Role of A20 in interferon-α-mediated functional restoration of myeloid dendritic cells in patients with chronic hepatitis C

KLHL20 and its role in cell homeostasis: A new perspective and therapeutic potential

The dual roles of A20 in cancer

A20 regulates inflammation through autophagy mediated by NF-κB pathway in human nucleus pulposus cells and ameliorates disc degeneration in vivo

A20 Protein Regulates Lipopolysaccharide-Induced Acute Lung Injury by Downregulation of NF-κB and Macrophage Polarization in Rats.

Interlinked destinies: How ubiquitin-proteasome and autophagy systems underpin neurocognitive outcomes